Technology | 2018.07.23
IDT's Customer Senseonics Receives FDA Approval for its Implantable Glucose Sensor
SAN JOSE, Calif., July 23, 2018 /PRNewswire/ -- Integrated Device Technology, Inc. (IDT) (NASDAQ: IDTI), announced that its customer Senseonics (Germantown, MD) received FDA approval for its Eversense® Continuous Glucose Monitoring (CGM) System for people with diabetes. The Eversense...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-glucose-sensor-300684424.html
